BioSuperior

BioSuperior is a preclinical stage biotherapeutics firm that develops technologies to cure lung disease and repair damaged lung tissue.

Last Funding Type: Grant
Last Funding Money Raised: $255.98K
Industries: Biotechnology,Information Technology,Life Science,Medical,Medical Device
Founded date: Jan 1, 2017
Number Of Employee: 1 - 10
Operating Status: Active

Number of Funding Rounds

Total Funding Amount

1

$255.98K

BioSuperior has raised a total of $255.98K in funding over 2 rounds. Their latest funding was raised on Jun 17, 2022 from a Grant round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jun 17, 2022	Grant	$255.98K	1	National Science Foundation	—	Detail

Number of Lead Investors

Number of Investors

1

BioSuperior is funded by 1 investors. National Science Foundation are the most recent investors.

Investor Name	Lead Investor	Funding Round
National Science Foundation	Yes	Grant